Stealthy startup Andas, Inc. has raised $654k of a $750k early stage funding round, according to this SEC disclosure.
The venture was formed, funded (in part) and operated by University medical student Joe Jensen and East Coast VC Tim Bemer, two former Notre Dame peers. Started 2012 based on IP sourced from the University of Minnesota, Andas aims to help ashma sufferers with a hardware device that connects with a smartphone:
“In the hands of patients, the Andas device could be used to direct a better course treatment. Through regular use, a doctor could improve dosage and tailor medications appropriately, particularly since some patients are steroid resistant,” says a University sponsored source.
We reported $155k of a previous round for Andas back in 2013, and another $30k was received when they won the 2014 Minnesota Cup Life Science Division.